Sanofi Hampered By Fitusiran Clinical Hold In Hemophilia

Reports Of Non-Fatal Thrombotic Events

 
• By Kevin Grogan
  
RNA
Fitusiran is a subcutaneously administered RNAi therapeutic • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapeutic Category